The efficacy of epidural corticosteroids in the treatment of sciatica was investigated by meta-analysis of all randomized controlled trials. Eleven suitable trials of good quality were identified involving a total of 907 patients.
Epidural corticosteroid agents are commonly used in the treatment of low back pain and sciatica. However, the efficacy of such treatment remains uncertain. Uncontrolled studies in large numbers of patients have generally shown beneficial effects of epidural steroids l ; however, the results from randomized placebo studies have involved fewer patients and shown variable efficacy.
In 1985 Bogduk and Cherry2 concluded that the literature was not definitive. From the open trials they reviewed, a proportion of patients appeared to benefit at least for short periods. Only two controlled trials were reviewed and these had conflicting results. In one triaP in highly selected patients with neurological and myelographic defects a negative result was observed; however, in an unselected group of patients' a positive effect was observed.
In the same year Kepes and DuncalfI reviewed six controlled trials of which fouf'!·5-7 showed no benefit of therapy with epdidural steroids whereas two studies'· B showed significant benefit. They concluded that while epidural steroid treatment may benefit some patients, statistical evidence was lacking and the treatment had not been scientifically proven. In 1986 Benzon reviewed the same trials and came to a similar conclusion.
In 1994 9 an Australian National Health and Medical Research Council working party updated a review of the literature and concluded that' 'there is no data from controlled trials that unreservedly vindicates the use of epidural steroids".
Most of the studies reviewed individually tended to produce only modest clinical effects and therefore failed to achieve statistical significance because of the small numbers of patients involved. None of the previous reviews has attempted to use techniques to quantitatively analyse the pooled responses from the available trials. We therefore have performed metaanalysis of all randomized trials using epidural steroids in the treatment of sciatica.
METHODS

Study Selection
A computerized literature search was conducted on Medline to identify published trials from the time of inception until the present. The terms, "epidural" or "caudal corticosteroid or methyl prednisolone", "treatment of sciatica (lumbosacral radiculopathy)", were used in combination with "randomized", "double blind" controlled prospective trial. In addition we examined published reviews and reference lists from clinical trials. To identify unpublished studies the makers of Depomedrol® (Upjohn) and recently published authors in the field were contacted.
Data Extraction
Data was extracted from the published reports by the two authors independently, with prior agreement on definitions of response and time course. Non-English articles were examined with translators. For each trial we documented the following: country of origin, diagnosis, duration of symptoms, randomization process, epidural technique used (caudal or lumbar approach), corticosteroid used, additional treatments, control, number of patients involved, efficacy variable, and the number of patients involved.
Quality Assessment
The methodological quality of the studies included in the review was assessed using a simplified scheme 'o involving the quality of random allocation, the extent to which primary analysis included every patient randomized to each group and the extent to which those assessing outcome were unaware of group assignment. For each of the three dimensions, a threepoint rating score was used ranging from a score of 3 if the effort to control potential bias had been maximal, to a score of one if there had been little or no effort.
Definitions
The main efficacy variable used in the analysis was relief of pain, which in most studies was measured using a visual analog scale. A clinically useful response was considered to be at least a 750/0 improvement or reduction in pain. Those patients who failed to improve, required surgery, or became worse, were considered as "non-responders". Patients lost to follow-up were regarded as "non-responders".
The analysis was also performed using a more strict definition of outcome; i.e., "responders" (where possible) were defined as patients with complete relief of pain, and those patients having some reduction, improvement, or no relief were considered "nonresponders".
Data Analysis
For each trial in the overview the number of expected responders (E) in the experimental group was calculated assuming that the steroid injection had no effect. The number of responders was then subtracted from the number that were actually observed in the experimental group (0). Adding these separate differences (O-E) and their variances allows the calculation of a statistic (and its variance) that is typical of the differences observed between experimental and control group in the trials. This was used to test the null hypothesis and also to estimate how worthwhile any differential effects were likely to be. The typical odds ratio (OR) and its 95% confidence interval (Cl) were calculated using a fixed effect model". This meant that patients in one trial were never compared directly with patients in another, but instead only patients within a trial were compared, thus avoiding differences in treatment, follow-up, and end point definitions. Heterogeneity was tested for by the Mantel-Haenszel approach12.
RESULTS
Description of Trials
A total of thirteen randomized trials3.4.6.S.'319 were identified and are summarized in Table 1 . One study (7) was excluded because response data could not be extracted from its cross-over design. Czarski 13 was also excluded from the final analysis because the followup period was not stated. An OR was calculated however, assuming the follow-up was short-term. There were no unpublished studies identified, none in progress, and one abandoned pilot study20.
The eleven trials analysed were placebo controlled parallel group designed studies involving 907 patients of both sexes. All trials only included patients with sciatica, predominantly due to lumbar disc disease of variable duration (1-63 months). One study included patients with arachnoiditis; however, all patients had clinical evidence of nerve root irritation or compression.
Active treatment included epidural methyl prednisolone 80 mg (ten studies), triamcinalone 80 mg (one study), and hydrocortisone 25 mg (one study), mixed with either saline (studies 3, 4, 14, 17) or local anaesthetic. The lumbar techniques were used in eight studies, and the caudal approach in five. In seven studies epidural placebos were used (saline or local anaesthetic), and in six an interspinous ligament injection.
The quality assessment of the trials was generally good with five studies scoring the maximum nine points. In five studies (7, 14, 18, 19, 20) the type of additional treatment is not stated. However, in all other studies analgesics were made available and in addition physiotherapy and anti-inflammatory medication was available in studies 4 and 8. The following assumptions were made during data extraction. In the Swerdlow studyl4 acute and chronic patients were combined and the assisted and relieved patients were designated responders in one analysis (75070 or better improvement) and assisted patients were considered nonresponders in the "total relief" analysis. Similarly in the Beliveau 6 study, those patients who were "completely relieved" or "improved" were responders and the analysis was repeated with responders being those "completely relieved" only. In the Dilke 4 study, responders were those patients whose pain was "clearly relieved" and "intermediate" groups. The analysis was also repeated where responders were only those "clearly relieved".
In Breivik et aP responders were those patients with "considerable relief". In Snoek et aP responders had relief of lower back and radiating pain. In Klenerman et aps the "improved" and "cured" patients were pooled as responders.
In Cuckler et al '6 spinal stenosis and herniated disc groups were pooled and "responders" were patients showing at least a 75% improvement. Mathews et al '7 described recovery according to a visual analog pain score. In Ridleyl8 response was designated as patients who showed "some improvement". In the Bush and Hillier '9 responders were those patients showing at least a 75% reduction in a visual analog pain score. In Popiolek et apo responders were patients showing a "prominent" or "marked" response. Figure 1 shows the effect of epidural (caudal and lumbar) steroid in the treatment of sciatica where a responder shows 75% or better improvement in the short term. The pooled odds ratio (OR) is 2.61 (95% Cl 1.80-3.77) when compared with placebo. Despite some variations in trial characteristics there was little evidence of significant heterogeneity (P=0.07).
The follow-up period varied between 24 hours and over one year, and for the purposes of analysis was divided into short-term (1-60 days), and long-term (12 weeks up to one year).
Efficacy of Epidural Steroids
When the data was analysed for near complete relief of pain, the pooled OR is 2. 79 (95% Cl 1.92-4.06) with  little evidence of heterogeneity (P=0.07) .
The OR for caudal epidural steroids was 3.80 (95%
Adverse Events
Four trials made no mention of adverse events; however, the pooled data from the other trials (431 patients), reported eleven dural taps (2.5070), 10 transient headache (2.3070 ), transient increase in pain (1.9%) and one patient (0.2%) complained of irregular periods. There was no meaningful comparison, however, between active and placebo groups. There was no report of longterm adverse events.
DISCUSSION
This overview provides reliable quantitative evidence from over 900 subjects that epidural administration of corticosteroids to patients with lumbar radicular pain (sciatica), is more effective in reducing pain in the short-and longterm than if placebo is used. This applies to both caudal and lumbar routes of administration and independent of any variation in methodology or design characteristics of trials included in the overview.
There are three possible methodological limitations of this overview which need to be considered: publication bias in the use of tabulated data predominantly derived from published reports and the meta-analysis based on a collection of small trials. It is possible that despite our efforts, some unpublished trials with less favourable results were not identified. Overdue reliance on the results of meta-analyses that are exclusively based on the results of small trials should be avoided, even when the combined effect is statistically signifiant 9 • This was highlighted in the recently published disparity between the results of meta-analysis of magnesium therapy for treatment of myocardial infarction (which suggested that the therapy was likely to be effective) and the results of a large mega-trial which found that the particular treatment had no effect 23 • In the case of the meta-analysis presented in this paper, it would be sensible to view the results with caution until a larger trial with sufficient power to confirm the estimated effect with certainty is conducted. This should be a priority for research in this area.
The clinical settings and the methodological limiations of these pooled studies are important to consider when interpreting the odds ratio. Most patients had unilateral sciatica with or without neurological signs due to disc prolapse or spinal stenosis of variable duration up to five years. They were mostly offered additional therapy including analgesics, benzodiazepines for muscle relaxation, anti-inflammatory medication, and some, physiotherapy.
The most important finding in this study was that despite the crude nature of the definitions of outcome, the effects of treatment were consistent whether outcome was partial or near complete relief of pain.
The content of the epidural injection varied between studies; the most common steroid used was methyl prednisolone either with saline, local anaesthetic or no vehicle. The epidural injection of local anaesthetic alone has been shown to be useful in sciatica 24 : however, it is generally used to confirm the epidural placement of the injection. Similar variation was found in the placebo injections used (Table 1) , with only two studies J • 19 using epidural saline injection. The number of injections was also variable. Despite these limitations this study shows significant short-term efficacy of epidural steroids in the treatment of sciatica which can be clinically useful, because it provides pain relief during natural spontaneous resolution of a herniated disc, minimizing opioid dependence, unnecessary surgery or hospitalization. Bush et aP' recently showed that 76% of disc herniations showed partial or complete resolution over twelve months with aggressive conservative management including up to three epidural steroid injections.
In the longterm ( > 12 months) efficacy is slightly less but may still be used for patients who are unsuitable for surgery.
The issue of safety of epidural steroids has recently been addressed by an expert panel 9 who found that the most common adverse events were technical problems with the procedure such as dural puncture. The weighted mean incidence of dural puncture in this pooled series was high (2.5%) but compared favourably to 5% in all series combined 9 • The reason for such a high dural puncture rate compared with obstetric epidurals (0.5-2%) 26 is not clear, but may be due to degenerative disc disease or epidural adhesions and partial obliteration of the space.
In conclusion we have presented quantitative evidence from pooled randomized trials that the administration of caudal or lumbar epidural steroids is effective in the management of lumbosacral radicular pain. Confirmation of these findings and the safety of epidural steroids should be addressed in a further study of appropriate design and adequate size.
